Publications
304
Citations
10,080
Est. group size
~3
Recurring co-author estimate
Active years
47
Publishing since 1980
Typically publishes in teams of ~4 · 44% small-team papers (≤3 authors) · across 33 venues
- Biological data governance in an age of AI
Science · 2026
- Living on the Edge: The Goldilocks Zone of Polyomavirus Replication and Persistence
Viruses · 2026
- Mirror microbial life and the dual use dilemma
mSphere · 2026
- Efficacy, safety, and tolerability of chenodeoxycholic acid (CDCA) in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized withdrawal, double-blind, placebo-controlled, crossover phase-3 study
Genetics in Medicine · 2025
- Two golden anniversaries in the biological sciences
mSphere · 2025
- 2024 Acknowledgment of <i>mSphere Ad Hoc</i> Reviewers
mSphere · 2025
- Incorporating the Intent of the Experiment into Gain-of-Function Oversight
Applied Biosafety · 2025
- P018: Safety and tolerability of chenodeoxycholic acid in pediatric patients with cerebrotendinous xanthomatosis (RESTORE): An open-label phase 3 study
Genetics in Medicine Open · 2025
- Final reflections
mSphere · 2025
- Biosecurity Assessments for Emerging Transdisciplinary Biotechnologies: Revisiting Biodefense in an Age of Synthetic Biology
Applied Biosafety · 2024
- Open‐label, single‐center, clinical study evaluating the safety, tolerability and clinical effects of pentosan polysulfate sodium in subjects with mucopolysaccharidosis I
Journal of Inherited Metabolic Disease · 2024
- P142: Efficacy, safety and tolerability of chenodeoxycholic acid in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized, placebo-controlled phase 3 study*
Genetics in Medicine Open · 2024
- A phase 2, randomized, double-blind, placebo-controlled, multicentre study to evaluate the efficacy and safety of pentosan polysulfate sodium in treating subjects with mucopolysaccharidosis VI: Study update
Molecular Genetics and Metabolism · 2024
- Evaluation of chenodeoxycholic acid treatment in adult patients with cerebrotendinous xanthomatosis: A randomized, placebo-controlled Phase 3 study (RESTORE)
Molecular Genetics and Metabolism · 2024
- †Evaluation of Chenodeoxycholic Acid Treatment in Adult Patients with Cerebrotendinous Xanthomatosis: A Randomized, Placebo-Controlled Phase 3 Study
Journal of clinical lipidology · 2024
- mSphere×35
- mBio×11
- Journal of Virology×11
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Applied and Environmental Microbiology×4
- Chelsey C. Spriggs
Medicine · University of Michigan
- D. Wilbert
Medicine · University of Michigan
- Blair A. Jenkins
Medicine · University of Michigan
- Christopher K. Bichakjian
Medicine · University of Michigan
- Doris Mangelberger
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile